Latest News and Insights June 2023

What Role Do Data Sciences Play in Drug Development?

Data science is a critical part of drug development. During clinical research studies, a significant amount of data is generated, which needs to be carefully processed, analyzed, interpreted, and reported. In order to make crucial decisions during a clinical study, high-quality data is needed quickly.

At Quotient Sciences, our Data Sciences department supports clinical trials conducted at our Miami, US, and Nottingham, UK, clinics, providing customers with rapid data and results to inform and accelerate their drug development programs decisions. Read more >>

Eleanor Row - Discovery to IND SpeakPharma Interview

Over the past 30 years, Quotient Sciences has worked on over 3,000 molecules across all stages of development. SpeakPharma interviews Eleanor Row, our Executive Director of Commercial who discusses the challenges that drug developers should be aware of when trying to quickly get their molecule from discovery to investigational new drug (IND) stage - and onward into the clinic. Read more >> ?

The First Kilograms of GMP Drug Substance

A core component of Quotient Sciences is our integrated capabilities in drug substance process research, development, and manufacturing. All are carried out at our state-of-the-art facility in Alnwick, UK. On site, our experienced team of process development chemists work alongside colleagues in analytical chemistry and material science to develop robust and commercially scalable synthetic processes and analytical methodologies, before supporting the manufacture of multi-kilogram quantities of Good Manufacturing Practice (GMP)-grade drug substance in our dedicated manufacturing suites. Read more >> ?